Acute Quadriplegic Myopathy Unrelated to Steroids or Paralyzing Agents: Quantitative EMG Studies

Background: Quadriplegic myopathy (QM) and its variants generally are described in critically ill patients who are exposed to steroids and nondepolarizing muscle blocking agents (NDMBAs). Methods: A patient with sepsis who was not exposed to steroids or an NDMBA infusion developed QM and was studied using serial quantitative electromyography. Results: Clinical and electrophysiological studies identified evidence of a severe myopathy and muscle biopsy showed necrosis, calcifications and selective loss of myosin filaments in non-necrotic fibers. Her clinical recovery paralleled rises in motor unit action potential (MUAP) amplitudes studied by serial automatic decomposition electromyography (ADEMG). Conclusion: QM can develop with sepsis and without significant exposure to steroids and NDMBAs. ADEMG can be a useful tool in electrophysiological evaluation of critically ill patients with weakness.

[1]  C. Vedeler,et al.  [Neuromuscular complications of sepsis]. , 2001, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[2]  P. Bergh,et al.  Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents , 1998, Neuromuscular Disorders.

[3]  J. Brucher,et al.  Acute corticosteroid myopathy in intensive care patients , 1997, Muscle & nerve.

[4]  M. Rich,et al.  Direct muscle stimulation in acute quadriplegic myopathy , 1997, Muscle & nerve.

[5]  A. Engel,et al.  Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain‐mediated proteolysis , 1997, Muscle & nerve.

[6]  R. Baer,et al.  Acute Myopathy Associated with Combined use of Corticosteroids and Neuromuscular Blocking Agents , 1996, The Annals of pharmacotherapy.

[7]  A. V. Cott,et al.  Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects , 1996, Annals of neurology.

[8]  C. Bolton,et al.  Neuromuscular disorders in critical illness. , 1996, Baillière's Clinical Neurology.

[9]  C. Bolton,et al.  Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. , 1996, Critical care medicine.

[10]  M. Rich,et al.  Muscle is electrically inexcitable in acute quadriplegic myopathy , 1996, Neurology.

[11]  M. Pedemonte,et al.  Ubiquitin expression in acute steroid myopathy with loss of myosin thick filaments , 1996, Muscle & nerve.

[12]  C. Jackson,et al.  Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids , 1994, Muscle & nerve.

[13]  D. Zochodne,et al.  Acute quadriplegic myopathy , 1994, Neurology.

[14]  D. Ramsay,et al.  Acute necrotizing myopathy of intensive care: Electrophysiological studies , 1994, Muscle & nerve.

[15]  A. Pestronk,et al.  Rapidly evolving myopathy with myosin‐deficient muscle fibers , 1994, Annals of neurology.

[16]  S. Ludwin,et al.  A Syndrome of Acute Severe Muscle Necrosis in Intensive Care Unit Patients , 1993, Journal of neuropathology and experimental neurology.

[17]  R. Massa,et al.  Loss and renewal of thick myofilaments in glucocorticoid‐treated rat soleus after denervation and reinnervation , 1992, Muscle & nerve.

[18]  C. Minetti,et al.  Acute quadriplegic myopathy , 1992, Neurology.

[19]  S. Carpenter,et al.  Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment , 1991, Muscle & nerve.

[20]  R. Griffiths,et al.  Necrotizing myopathy in critically‐ill patients , 1991, The Journal of pathology.

[21]  K. McGill,et al.  Automatic decomposition electromyography (ADEMG): validation and normative data in brachial biceps. , 1985, Electroencephalography and clinical neurophysiology.

[22]  W. van Marle,et al.  Acute hydrocortisone myopathy. , 1980, British medical journal.

[23]  I. MacFarlane,et al.  SEVERE MYOPATHY AFTER STATUS ASTHMATICUS , 1977, The Lancet.

[24]  T. O'Grady.  The compendium of pharmaceuticals and specialties. , 1977, Canadian Medical Association journal.

[25]  L. Ose.  Letter: L.D.L. and total cholesterol in cord-blood screening for familial hypercholesterolaemia. , 1975, Lancet.